Hangzhou Tigermed Consulting (SHE:300347) controlling shareholders Ye Xiaoping and Cao Xiaochun face combined fines of up to 1 million yuan for late disclosures of share reductions, according to a Saturday filing with the Shenzhen bourse.
The two shareholders failed to submit equity change reports in 2019 on time, retroactively submitting the disclosure on May 12, 2026. The tandem also failed to disclose on time a stake reduction in 2022, only disclosing the matter in May.